down arrow

Pharmarise Holdings Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3802320006
JPY
531.00
-1 (-0.19%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
May'25
Feb'25
Nov'24
Aug'24
May'24
Feb'24
Nov'23
Net Sales
16,929.00
16,035.00
15,313.00
15,231.00
13,792.00
13,726.00
13,477.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
16,929.00
16,035.00
15,313.00
15,231.00
13,792.00
13,726.00
13,477.00
Raw Material Cost
14,710.00
13,926.00
13,394.00
13,275.00
11,939.00
11,682.00
11,476.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
59.00
51.00
38.00
30.00
24.00
14.00
15.00
Selling and Distribution Expenses
2,021.00
2,113.00
1,871.00
1,903.00
1,797.00
1,889.00
1,618.00
Other Expenses
-5.90
-5.10
-3.80
-3.00
-2.10
-1.10
-1.20
Total Expenditure (Excl Depreciation)
16,731.00
16,039.00
15,265.00
15,178.00
13,739.00
13,574.00
13,097.00
Operating Profit (PBDIT) excl Other Income
198
-4
48
53
53
152
380
Other Income
17.00
8.00
-25.00
1.00
3.00
-21.00
1.00
Operating Profit (PBDIT)
623.00
386.00
382.00
398.00
358.00
428.00
673.00
Interest
59.00
51.00
38.00
30.00
24.00
14.00
15.00
Exceptional Items
-118.00
-15.00
5.00
-1.00
-649.00
-18.00
-17.00
Gross Profit (PBDT)
2,219.00
2,109.00
1,919.00
1,956.00
1,853.00
2,044.00
2,001.00
Depreciation
408.00
382.00
359.00
344.00
302.00
297.00
292.00
Profit Before Tax
36.00
-62.00
12.00
22.00
-618.00
99.00
350.00
Tax
135.00
99.00
0.00
156.00
-88.00
194.00
194.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-96.00
-158.00
17.00
-131.00
-528.00
-97.00
150.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-96.00
-158.00
17.00
-131.00
-528.00
-97.00
150.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.00
-5.00
-5.00
-2.00
-1.00
2.00
5.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-97.00
-163.00
12.00
-133.00
-529.00
-95.00
155.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
6,869.00
6,948.00
7,091.00
7,004.00
7,362.00
7,873.00
8,312.00
Earnings per share (EPS)
-8.36
-14.0
1.58
-11.65
-46.96
-8.42
15.12
Diluted Earnings per share
-8.36
-14.0
1.58
-11.65
-46.96
-8.42
15.12
Operating Profit Margin (Excl OI)
1.17%
-0.02%
0.31%
0.35%
0.38%
1.11%
2.82%
Gross Profit Margin
2.62%
2.0%
2.42%
2.4%
-2.29%
2.89%
4.76%
PAT Margin
-0.57%
-0.99%
0.11%
-0.86%
-3.83%
-0.71%
1.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended May 2025 is 10.55%

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended May 2025 is -908.33%

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended May 2025 is 48.89%

stock-summary

Interest

QoQ Growth in quarter ended May 2025 is 55.26%

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended May 2025 has improved from Nov 2024

Compare Quarterly Results Of Pharmarise Holdings Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
16,929.00
10.00
16,919.00
169,190.00%
Other Operating Income
0.00
0.00
0.00
Total Operating income
16,929.00
10.00
16,919.00
169,190.00%
Raw Material Cost
14,710.00
1.58
14,708.42
930,912.66%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
59.00
0.00
59.00
Selling and Distribution Expenses
2,021.00
45.19
1,975.81
4,372.23%
Other Expenses
-5.90
6.55
-12.45
-190.08%
Total Expenditure (Excl Depreciation)
16,731.00
112.27
16,618.73
14,802.47%
Operating Profit (PBDIT) excl Other Income
198.00
-102.27
300.27
293.61%
Other Income
17.00
35.65
-18.65
-52.31%
Operating Profit (PBDIT)
623.00
-66.62
689.62
1,035.15%
Interest
59.00
0.00
59.00
Exceptional Items
-118.00
0.00
-118.00
Gross Profit (PBDT)
2,219.00
8.42
2,210.58
26,253.92%
Depreciation
408.00
0.00
408.00
Profit Before Tax
36.00
-66.63
102.63
154.03%
Tax
135.00
0.25
134.75
53,900.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
-96.00
-66.88
-29.12
-43.54%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-96.00
-66.88
-29.12
-43.54%
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.00
0.00
-1.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-97.00
-66.88
-30.12
-45.04%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
6,869.00
1,653.27
5,215.73
315.48%
Earnings per share (EPS)
-8.36
-5.26
-3.10
-58.94%
Diluted Earnings per share
-8.36
-5.26
-3.10
-58.94%
Operating Profit Margin (Excl OI)
1.17%
-1,022.74%
0.00
1,023.91%
Gross Profit Margin
2.62%
-666.26%
0.00
668.88%
PAT Margin
-0.57%
-668.77%
0.00
668.20%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,692.90 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 10.55%

stock-summary

YoY Growth in quarter ended May 2025 is 22.75% vs 3.70% in May 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -9.70 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is -908.33%

stock-summary

YoY Growth in quarter ended May 2025 is 81.66% vs -510.08% in May 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 60.60 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 48.89%

stock-summary

YoY Growth in quarter ended May 2025 is 70.70% vs -57.89% in May 2024

Quarterly - Interest
Interest 5.90 Million
in May 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended May 2025 is 55.26%

stock-summary

YoY Growth in quarter ended May 2025 is 145.83% vs 60.00% in May 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 1.17%
in May 2025

Figures in %
stock-summary

QoQ Growth in quarter ended May 2025 has improved from Nov 2024

stock-summary

YoY Growth in quarter ended May 2025 has improved from May 2024

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."